Article Data

  • Views 1171
  • Dowloads 128

Original Research

Open Access

Ovarian carcinoma presenting with axillary lymph node metastasis: a case report

  • F. Ceccarelli1,*,
  • S. Barberi1
  • A. Pontesilli1
  • S. Zancla1
  • E. Ranieri1

1Department of Surgery “P. Valdoni”, Sapienza University of Rome, Rome, Italy

DOI: 10.12892/ejgo201102237 Vol.32,Issue 2,March 2011 pp.237-239

Published: 10 March 2011

*Corresponding Author(s): F. Ceccarelli E-mail: fra.ceccarelli@virgilio.it

Abstract

Ovarian cancer is usually limited to the abdomen and frequently remains confined. The occurrence of extrabdominal mestastases is unusual. In this report we describe a rare case of axillary involvement at initial presentation of ovarian cancer in a 48-year-old woman. The axillary mass was the only clinical abnormality. Cytological and histological findings, performed on axillary lymph nodes, showed the presence of psammoma bodies and specific immunohistochemical tumor markers (OC-125 and WT1), supporting the evidence of a metastatic axillary lymphadenopathy from ovarian cancer. Subsequently, chest and abdominopelvic computed tomography showed a right ovarian complex mass of 30 x 25 mm and biochemical tests showed high levels of CA125. Surgical therapy was performed. Histology confirmed the diagnosis, evidencing a poorly differentiated serous-papillary carcinoma of the right ovary. In conclusion, cytological and histological findings can play a crucial role in suggesting the correct origin of a metastatic adenocarcinoma when the clinical presentation is atypical.

Keywords

Metastatic axillary Lymphadenopathy; Ovarian cancer; Psammoma bodies; Fine-needle aspiration biopsy

Cite and Share

F. Ceccarelli,S. Barberi,A. Pontesilli,S. Zancla,E. Ranieri. Ovarian carcinoma presenting with axillary lymph node metastasis: a case report. European Journal of Gynaecological Oncology. 2011. 32(2);237-239.

References

[1] Bonadonna G., Robustelli Della Cuna G.: “Medicina Oncologica. Neoplasie dell’ovaia”. In: Masson Editor, 6th ed. Milano, 2003, 1089.

[2] Cheng B., Lu W., Xiaoyun W., YaXia C., Xie X.: “Extra-abdominal metastases from epithelial ovarian carcinoma. An analysis of 20 cases”. Int. J. Gynecol. Cancer, 2009, 19, 611.

[3] Cormio G., Rossi C., Cazzolla A., Resta L., Loverro G., Greco P., Selvaggi C.: “Distant metastases in ovarian carcinoma”. Int. J. Gynecol. Cancer, 2003, 13, 125.

[4] Skagias L., Ntinis A., Vasou O., Kondi-Pafiti A., Politi E.: “Ovarian carcinoma presenting with axillary lymph node metastasis: a case diagnosed by fine-needle aspiration and brief review of literature”. Diagn. Cytopathol., 2008, 36, 891.

[5] Ang D., Ng K.Y., Tan H.K., Chung A.Y., Yew B.S:, Lee V.K.: “Ovarian carcinoma presenting with isolated controlateral inguinal lymph node metastasis: a case report”. Ann. Acad. Med. Singapore, 2007, 36, 428.

[6] Hockstein S., Keh P., Lurain J.R., Fishman D.A.: “Ovarian carcinoma initially presenting as metastatic axillary lymphadenopathy”. Gynecol. Oncol., 1997, 65, 543.

[7] Fanti S., Nanni C., Castellucci P., Farsad M., Rampin L., Gross M.D. et al.: “Supra-clavicular lymph node metastatic spread in patients with ovarian cancer discoded at 18F-FDG-PET/CT: an unusual finding”. Cancer Imaging, 2006, 23, 20.

[8] Aydin Ç., Unalp H.R., Balog˘lu A., Inci A.G., Yig˘it S., Yavuzcan A.: “Axillary lymph node metastasis from serous ovarian cancer: a case report and review of literature”. Arch. Gynecol. Obstet., 2009, 279, 203.

[9] Benedetti-Panici P., Greggi S., Maneschi F., Scambia G., Amoroso M., Rabitti C., Mancuso S.: “Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer”. Gynecol. Oncol., 1993, 51, 150.

[10] Ferenczy A., Talens M., Zoghby M., Hussain S.S.: “Ultrastructural studies on the morphogenesis of psammoma bodies in ovarian serous neoplasia”. Cancer, 1997, 36, 2451.

[11] Recine M.A., Deavers M.T., Middleton L.P., Silva E.G., Malpica A.: “Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall”. Am. J. Surg. Pathol., 2004, 28, 1646.

[12] Das D.K.: “Psammoma body: a product of dystrophic calcification or of a biologically active process that aims al limiting the growth and spread of tumor?”. Diagn. Cytopathol., 2009, 37, 534.

[13] Parwani A.V., Chan T.Y., Ali S.Z.: “Significance of psammoma bodies in serous cavity fluid. A cytophathologic analysis”. Cancer, 2004, 102, 87.

[14] Monteagudo C., Merino M.J., La Porte N., Neumann R.D.: “Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasm involving the ovary”. Hum. Pathol., 1991, 22, 368.

Submission Turnaround Time

Top